Objective Patent foramen ovale (PFO) can be detected in up to 43% of patients with
cryptogenic cerebral ischemia undergoing investigation with transesophageal …

Patent foramen ovale (PFO) is growing in clinical interest because of a renewed focus on
embolic stroke of undetermined source (ESUS), the PFO attributable fraction (the 10-point …

Objective To assess the association between migraine and cryptogenic ischemic stroke
(CIS) in young adults, with subgroup analyses stratified by sex and presence of patent …

BACKGROUND: Right to left shunt (RLS), including patent foramen ovale, is a recognized
risk factor for stroke. RLS/patent foramen ovale diagnosis is made by transthoracic …

Background and Purpose—Recurrent cerebrovascular events are frequent in medically
treated patients with patent foramen ovale (PFO), but it still remains unclear whether PFO is …

OBJECTIVE: Low Ankle-Brachial Blood Pressure Index (ABI) identifies patients with
symptomatic and asymptomatic peripheral arterial disease (PAD). We sought to investigate …

Background In patients with patent foramen ovale (PFO), strategies are needed to identify
patients at higher risk, who might benefit from PFO closure. Methods We studied the …

ABSTRACT BACKGROUND There are limited data available regarding symptomatic
intracranial atherosclerosis (SIA) prevalence in Caucasians. We sought to investigate SIA …

Background and purpose The diagnostic utility of transesophageal echocardiography (TEE)
in patients with cryptogenic ischaemic stroke (IS) or transient ischaemic attack (TIA) remains …

Background Worldwide, about 1.3 million annual ischaemic strokes (IS) occur in adults
aged< 50 years. Of these early-onset strokes, up to 50% can be regarded as cryptogenic or …